You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KEYNOTE-567

Showing 1 - 25 of 124
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (biological, drug, other)

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • Pembrolizumab 200 mg
  • +11 more
  • Los Angeles, California
  • +30 more
Aug 12, 2022

Triple-negative Breast Cancer Trial (Taxane and Carboplatin, Short-term Sintilimab, Surgery)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Taxane and Carboplatin
  • +2 more
  • (no location specified)
Apr 25, 2023

Endometrial Tumors Trial in Worldwide (biological, drug, radiation)

Recruiting
  • Endometrial Neoplasms
  • Pembrolizumab
  • +8 more
  • Birmingham, Alabama
  • +228 more
Jul 29, 2022

Stage III/IV Melanoma Trial in Worldwide (tavokinogene telseplasmid, Pembrolizumab, ImmunoPulse)

Recruiting
  • Stage III/IV Melanoma
  • tavokinogene telseplasmid
  • +2 more
  • Tucson, Arizona
  • +37 more
Dec 21, 2022

Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT

Recruiting
  • Lung Cancer Stage III
  • Lung Cancer Stage IV
    • Brest, France
      Chu Brest
    Aug 16, 2023

    Hepatobiliary Tumors Tissue Samples Acquisition

    Recruiting
    • Hepatocellular Carcinoma
    • +7 more
    • Gene expression analysis
    • +10 more
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences & Peking Union Medical Colle
    Jun 8, 2022

    PFS, OS Trial in Qingdao (PD-1 inhibitor, Bevacizumab, Carboplatin, Cisplatin, Pemtrexed)

    Recruiting
    • PFS
    • OS
    • PD-1 inhibitor, Bevacizumab, Carboplatin, Cisplatin, Pemtrexed
    • Qingdao, Shandong, China
      Qingdao central Hospital
    Feb 23, 2022

    Emulation of KEYNOTE-189 Trial Using Electronic Health Records

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Metastatic Lung Cancer
    • Boston, Massachusetts
      Aetion
    Jun 14, 2023

    Oral Squamous Cell Carcinoma Trial (Tislelizumab, Albumin paclitaxel, Cisplatin)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • (no location specified)
    May 7, 2023

    And Incidence of Neuropsychological Dysfunction in ICU

    Recruiting
    • Critical Illness
    • Intensive Care Unit Delirium
      • Chicago, Illinois
      • +1 more
      Nov 3, 2022

      HER2-positive Gastric Cancer, Immunotherapy Trial in Shanghai (Disitamab Vedotin combined with fruquintinib and Tislelizumab)

      Recruiting
      • HER2-positive Gastric Cancer
      • Immunotherapy
      • Disitamab Vedotin combined with fruquintinib and Tislelizumab
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 8, 2023

      Effect of Drug Trial in Sapporo (Docetaxel, Pembrolizumab)

      Not yet recruiting
      • Effect of Drug
      • Sapporo, Hokkaido, Japan
        Hokkaido University Hospital
      Feb 12, 2022

      Breast Cancer Trial in Guangzhou (Chidamide Plus Toripalimab Plus Paclitaxel)

      Recruiting
      • Breast Cancer
      • Chidamide Plus Toripalimab Plus Paclitaxel
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Feb 19, 2023

      Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

      Not yet recruiting
      • Carcinoma
      • +7 more
      • XNW5004
      • Pembrolizumab 25 mg/mL Solution for Injection
      • (no location specified)
      Aug 31, 2023

      Locally Advanced Head Neck Cancer Trial in Kuwait (Pembrolizumab)

      Recruiting
      • Locally Advanced Head and Neck Cancer
      • Kuwait, Kuwait
        Kuwait Cancer Control Center
      Apr 13, 2021

      Hepatocellular Carcinoma Trial (Pembrolizumab)

      Active, not recruiting
      Has Results
      • Hepatocellular Carcinoma
      • Pembrolizumab
      • (no location specified)
      Dec 15, 2022

      Advanced Malignancies Trial in Denmark, Hungary, Russian Federation (BI-1808, Pembrolizumab 25 Mg/mL Solution for Injection)

      Recruiting
      • Advanced Malignancies
      • BI-1808
      • Pembrolizumab 25 Mg/mL Solution for Injection
      • Copenhagen, Denmark
      • +11 more
      Sep 9, 2022

      Urothelial Cancer Trial (pembrolizumab)

      Completed
      Has Results
      • Urothelial Cancer
      • pembrolizumab
      • (no location specified)
      Aug 18, 2022

      Renal Cell Carcinoma (RCC) Trial in Worldwide (Pembrolizumab, Epacadostat, Sunitinib)

      Active, not recruiting
      Has Results
      • Renal Cell Carcinoma (RCC)
      • Scottsdale, Arizona
      • +139 more
      Jun 3, 2022

      Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo

      Not yet recruiting
      • Colorectal Adenocarcinoma
      • +2 more
      • Trondheim, Trondelag, Norway
      • +2 more
      Aug 15, 2022

      NSCLC Trial in Worldwide (Pembrolizumab, Pemetrexed, Carboplatin)

      Completed
      Has Results
      • Non-Small Cell Lung Cancer
      • Aurora, Colorado
      • +14 more
      Oct 21, 2022

      Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors Trial in Worldwide (biological, drug, other)

      Recruiting
      • Ovarian Cancer
      • +2 more
      • Pembrolizumab
      • +4 more
      • Phoenix, Arizona
      • +178 more
      Jan 25, 2023

      Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)

      Recruiting
      • Melanoma
      • +4 more
      • Pembrolizumab
      • Aurora, Colorado
      • +18 more
      Jan 5, 2023

      Renal Cell Carcinoma Trial (Pembrolizumab)

      Completed
      Has Results
      • Renal Cell Carcinoma
      • Pembrolizumab
      • (no location specified)
      Aug 17, 2022